Login to Your Account

All of the UK's public research funding agencies, from arts and humanities to engineering and physical sciences, are uniting in a "war cabinet" to tackle antimicrobial resistance (AMR) in a coordinated fashion across all fronts, from drug discovery to monitoring resistant microbes in the environment and influencing behavior to prevent and control infections.
LONDON – The row over European governments sanctioning off-label use of drugs to cut their pharmaceuticals bills is escalating after the lower house of the French parliament voted in favor of a law that would allow off-label use even if on-label treatments are available.
LONDON – The €3.3 billion Innovative Medicines Initiative 2 (IMI 2) is now formally under way, following the launch of the first two calls in which €49 million (US$66.8 million) is available for research in type I diabetes and retinal diseases.
More EUROPE Headlines

Cast Your Vote

Has biotech’s bubble burst?: